1.原文連結(必須檢附)： http://reut.rs/1GqIacs
2.原文內容：
The United States and Australia have reached a compromise on the
length of monopoly protection allowed for new biotech drugs in a
development that could clear the way for a sweeping Pacific Rim
trade deal, Japanese media reported on Sunday.
日本媒體報道，美國與澳洲就生科新藥專利保護期達成妥協，可望為TPP鋪平
道路。
The amount of time allowed for pharmaceutical companies to have
exclusive rights to the clinical data for biological drugs has been
the last major sticking point in the Trans-Pacific Partnership
talks in Atlanta.
新藥的臨床數據保護期是TPP談判中最後一個主要節點。
The compromise under discussion would grant a data exclusivity
period that would be eight years, in effect, Kyodo reported. That
would be in line with a U.S. proposal from last week. Reuters
could not immediately confirm the report.
共同社報道，正在談判中的數據保護期事實上為8年，與美國上週的提案
相符。路透無法立即驗證此報導
3.心得/評論(必需填寫)：
TPP最後的堡壘有三個
1. 汽車原產地規則，已妥協為50%左右(日本與墨西哥，加拿大)
2. 乳製品開放，紐西蘭已承諾讓步（紐西蘭與加拿大，美國，日本）
3. 生科藥物專利保護期，看起來澳洲已經放棄了5年的要求，讓步于美國
TPP明日有望達成